Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- SPWH -11.3%, DLTR -3% (alsoreview of strategic alternatives of the Company's Family Dollar business), THO -1.5%, PVH -1.4% (also CEO of Tommy Hilfiger Global and PVH Europe to leave)
Other news:
- MNMD -15% (after Lykos Therapeutics provided update on FDA Advisory Committee Meeting for investigational MDMA-assisted therapy for PTSD)
- EPRX -13.3% (to Present Data from the Phase 2 SPRINGBOARD Study in Osteoarthritis of the Knee at EULAR European Congress of Rheumatology 2024)
- IMMP -12.4% (successfully completes institutional placement and institutional component of entitlement offer)
- CANF -9.4% (announces an update on the status of its oncological lead drug candidate, Namodenoson in the treatment of advanced liver cancer)
- ANNX -3.2% ($125 mln share offering)
- ZVRA -3.2% (files $350 mln mixed shelf securities offering)
- YEXT -1.4% (to cut workforce by 12%)
Analyst comments:
- MED -17.7% (downgraded to Underperform from Neutral at DA Davidson)
- RLMD -6.4% (downgraded to Sell from Neutral at Goldman)
- TITN -1.7% (downgraded to Neutral from Buy at B. Riley Securities)